Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Curaleaf Holdings Inc.

Healthcare CA CURA

13.84CAD
-0.72(4.95%)

Last update at 2026-06-12T20:00:00Z

Day Range

13.7115.00
LowHigh

52 Week Range

0.996.97
LowHigh

Fundamentals

  • Previous Close 14.56
  • Market Cap3259.89M
  • Volume156682
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA222.06M
  • Revenue TTM1268.14M
  • Revenue Per Share TTM1.66
  • Gross Profit TTM 631.02M
  • Diluted EPS TTM-0.44

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -79.58318M -117.62900M -167.85517M -112.59470M -77.97841M
Minority interest -2.91700M - - - -
Net income -235.11500M -215.42300M -379.52792M -481.81467M -258.19370M
Selling general administrative 458.07M 398.74M 392.79M 408.15M 373.90M
Selling and marketing expenses - 48.48M 41.99M 39.75M 41.84M
Gross profit 498.20M 639.25M 644.70M 667.70M 607.67M
Reconciled depreciation 216.04M - - - -
Ebit 25.90M -17.01300M 57.88M 84.60M 73.43M
Ebitda 169.76M 233.14M 343.90M 300.25M 240.89M
Depreciation and amortization 143.87M 250.16M 286.02M 215.64M 167.45M
Non operating income net other - - - - -
Operating income 25.90M 20.20M 57.88M 84.60M 73.43M
Other operating expenses 1264.44M 1322.61M 1759.65M 1575.81M 1426.01M
Interest expense 102.59M 100.62M 100.38M 88.84M 90.26M
Tax provision 123.69M 98.59M - - -
Interest income 0.66M 93.22M - - -
Net interest income -100.16600M - - - -
Extraordinary items - -5.78600M - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 125.85M 98.59M 154.66M 232.80M 191.13M
Total revenue 1290.33M 1342.80M 1817.53M 1660.41M 1499.45M
Total operating expenses 472.30M 619.05M 586.82M 583.10M 534.24M
Cost of revenue 792.14M 703.55M 1172.83M 992.71M 891.78M
Total other income expense net -105.47869M -137.82600M -225.73380M -197.19955M -151.41329M
Discontinued operations - - - - -
Net income from continuing ops -244.19700M - - - -
Net income applicable to common shares - -215.42300M - - -
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2840.14M 2949.54M 4083.15M 4626.56M 3922.17M
Intangible assets 1009.27M 1085.40M 1172.44M 1213.30M 1010.01M
Earning assets - - - - -
Other current assets 265.60M 7.19M 63.55M 283.57M 147.04M
Total liab 2001.39M 2088.32M 2538.68M 2728.52M 1818.91M
Total stockholder equity 754.97M 861.21M 1385.38M 1733.94M 1952.98M
Deferred long term liab - - - - -
Other current liab 151.94M - 452.51M 451.79M 160.26M
Common stock - 2237.47M - - 2811.70M
Capital stock 0.00000M - - - -
Retained earnings -1584.35545M -1356.17400M -1504.19427M -1164.65269M -618.25887M
Other liab - - - - -
Good will 633.96M 628.88M 826.27M 847.02M 765.26M
Other assets - 0.40M 0.00000M 0.00000M -
Cash 101.39M - 121.07M 221.10M 378.10M
Cash and equivalents - 107.23M - - -
Total current liabilities 293.78M 387.93M 651.43M 673.23M 399.46M
Current deferred revenue - - 1.14M 0.92M 175.80M
Net debt 933.83M - 1327.04M 1333.85M 645.22M
Short term debt 67.25M 0.00000M 93.19M 111.06M 29.62M
Short long term debt 35.73M - - - -
Short long term debt total 1035.22M - 1448.11M 1554.95M 1023.32M
Other stockholder equity 2341.13M -20.08000M 2905.23M 2923.78M 76.55M
Property plant equipment - 768.11M - - -
Total current assets 447.81M 429.68M 551.97M 884.00M 917.83M
Long term investments 0.26M - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 80.82M 61.27M 82.65M 61.22M 79.25M
Long term debt 512.92M 466.90M - - -
Inventory 225.02M 220.65M 284.70M 318.12M 313.45M
Accounts payable 74.59M - 104.59M 109.47M 33.79M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1.80471M - -15.65837M -25.19394M -317.00644M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 13.55M - 589.76M 673.50M 489.09M
Deferred long term asset charges - - - - -
Non current assets total 2392.33M - 3531.18M 3742.55M 3004.34M
Capital lease obligations 278.31M - - - -
Long term debt total - 819.27M - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -0.17300M - - - -
Change to liabilities - - - - -
Total cashflows from investing activities -71.80435M -93.82900M - - -
Net borrowings -34.16500M - - - -
Total cash from financing activities -74.77953M -54.23800M -96.07477M 54.41M 457.79M
Change to operating activities - - - - -
Net income -251.43986M -216.22100M -310.17831M -336.49918M -258.19370M
Change in cash -10.90934M 15.41M -100.02546M -157.00075M 284.40M
Begin period cash flow 112.30M 91.82M 221.10M 378.10M 93.69M
End period cash flow 101.39M 107.23M 121.07M 221.10M 378.10M
Total cash from operating activities 140.35M 162.57M 101.58M 60.41M -73.06754M
Issuance of capital stock - - - - -
Depreciation 219.82M 250.16M 286.02M 215.64M 167.45M
Other cashflows from investing activities -5.99514M -3.75600M - - -
Dividends paid - - - - -
Change to inventory -3.78919M 2.99M 13.30M -20.96375M -116.75134M
Change to account receivables 6.82M 2.21M 0.15M -26.32348M -31.66552M
Sale purchase of stock - 0.16M - - -
Other cashflows from financing activities -49.71939M -11.69400M -42.30594M -19.65538M -6.25236M
Change to netincome - - - - -
Capital expenditures 64.55M 98.15M 94.89M 175.29M 215.59M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 122.49M 103.69M 46.08M 85.98M -69.94950M
Stock based compensation 35.74M 25.70M 20.01M 28.02M 39.48M
Other non cash items 84.15M 53.91M 675.60M 528.33M 597.15M
Free cash flow 75.80M 64.42M 6.69M -114.87555M -288.65313M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CURA
Curaleaf Holdings Inc.		 -0.72 4.95% 13.84 - 138.89 2.57 3.14 2.47 13.10
BHC
Bausch Health Companies Inc		 -0.11 1.53% 7.09 13.98 1.35 0.28 18.74 2.12 6.84
CRON
Cronos Group Inc		 -0.1 2.59% 3.76 - 32.15 9.80 0.95 1.47 1.90
TLRY
Tilray Inc		 -0.17 2.38% 6.96 - 1000.00 1.28 0.53 1.08 -2.299
GUD
Knight Therapeutics Inc.		 0.10 1.07% 9.48 - 48.54 1.64 0.96 1.60 11.97

Reports Covered

Stock Research & News

View All

Profile

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.

Curaleaf Holdings Inc.

290 Harbor Drive, Stamford, CT, United States, 06902

Key Executives

Name Title Year Born
Mr. Boris Alexis Jordan CEO & Chairman 1966
Mr. Joseph F. Lusardi Executive Vice-Chairman 1975
Mr. Edward Kremer Chief Financial Officer 1972
Mr. Peter Laurence Clateman J.D. Chief Legal Officer 1968
Mr. Matthew S. Darin Special Advisor NA
Mr. Camilo Russi Lyon Chief Investment Officer NA
Ms. Christine Taylor Chief Accounting Officer NA
Mr. Jakob Feinstein Manager of Investor Relations NA
Mr. James S. Shorris Chief Compliance Officer 1961
Ms. Kate Lynch Executive Vice President of Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.